Table 1 Allele frequencies of the ERα gene polymorphism in patients with AITDs and in control subjects

allele ^*1

20 (7.7%)

13 (7.0%)

24 (6.3%)

allele ^*2

40 (15.3%)

34 (18.3%)

88 (23.2%)

allele ^*3

49 (18.7%)

25 (13.4%)

58 (15.3%)

allele ^*4

32 (12.3%)

26 (14.0%)

39 (10.3%)

allele ^*5

7 (2.7%)

2 (1.1%)

13 (3.4%)

allele ^*6

10 (3.8%)

8 (4.3%)

12 (3.2%)

allele ^*7

19 (7.3%)

12 (6.5%)

23 (6.1%)

allele ^*8

10 (3.8%)

12 (6.5%)

16 (4.2%)

allele ^*9

15 (5.8%)

10 (5.4%)

23 (6.1%)

allele ^*10

11 (4.2%)

10 (5.4%)

15 (3.9%)

allele ^*11

17 (6.5%)

12 (6.5%)

37 (9.7%)

allele ^*12

14 (5.4%)

12 (6.5%)

18 (4.7%)

allele ^*13

10 (3.8%)

7 (3.8%)

10 (2.6%)

allele ^*14

5 (1.9%)

2 (1.1%)

2 (0.5%)

allele ^*15

1 (0.4%)

0 (0%)

1 (0.3%)

allele ^*16

0 (0%)

0 (0%)

1 (0.3%)

allele ^*17

1 (0.4%)

1 (0.5%)

0 (0%)